InvestorsHub Logo
Followers 117
Posts 20170
Boards Moderated 0
Alias Born 06/13/2011

Re: Whalatane post# 31

Tuesday, 04/04/2023 2:11:19 PM

Tuesday, April 04, 2023 2:11:19 PM

Post# of 35
As an update . After doing more research into NVS's Cosentyx and their P 3 trial a week or so ago .....I sold most of my KZR position ...retaining only 100 shares..
I liked the KZR data but now realize that if the Cosentyx LN trial succeeds ( primary completion Jan 2025 ) , they will file for accelerated approval and dominate the non generic drug portion of this market.
The lesson from this .
Know the competition and don't fall in love with a stock
Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KZR News